The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial

The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial

In a randomized controlled trial, Koichi Node and colleagues assess the efficacy of sitagliptin in limiting atherosclerosis among patients over 29 years of age living in Japan.

Bibliographic Details
Main Authors: Oyama, Jun-ichi, Murohara, Toyoaki, Kitakaze, Masafumi, Ishizu, Tomoko, Sato, Yasunori, Kitagawa, Kazuo, Kamiya, Haruo, Ajioka, Masayoshi, Ishihara, Masaharu, Dai, Kazuoki, Nanasato, Mamoru, Sata, Masataka, Maemura, Koji, Tomiyama, Hirofumi, Higashi, Yukihito, Kaku, Kohei, Yamada, Hirotsugu, Matsuhisa, Munehide, Yamashita, Kentaro, Bando, Yasuko K., Kashihara, Naoki, Ueda, Shinichiro, Inoue, Teruo, Tanaka, Atsushi, Node, Koichi
Format: Online
Language:English
Published: Public Library of Science 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924847/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924847/

Similar Items